H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: GIANT BIOGENE(02367) the Revenue is 3.367 B (-1.16%), Beat estimate;the EBIT is 1.253 B (-15.85%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
3.37B1.16%
3.34B1.92%
+0.03B0.76%
EBITExceed expectations
1.25B15.85%
1.15B22.84%
+0.10B6.99%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf